EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapid, accurate, and reproducible de novo prediction of resistance to antituberculars

Xibei Zhang iD, Shunzhou Wan iD, Agastya P Bhati iD, Philip W Fowler iD, Peter V Coveney iD

mSphere · 2025

DOI: 10.1128/msphere.00571-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2025. Verfasst von Xibei Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Computational Science, Department of Chemistry, University College London, London, United Kingdom. Hauptthemen laut MEDLINE: Antitubercular Agents, Tuberculosis, Rifampin, Drug Resistance, Bacterial. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, Medical Research Council, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As one of the deadliest infectious diseases in the world, tuberculosis is responsible for millions of new cases and deaths reported annually. The rise of drug-resistant tuberculosis, particularly resistance to first-line treatments like rifampicin, presents a critical challenge for global health, which complicates the treatment strategies and calls for effective diagnostic and predictive tools. In this study, we apply an ensemble-based molecular dynamics computer simulation method, TIES_PM, to estimate the binding affinity through free energy calculations and predict rifampicin resistance in RNA polymerase. By analyzing 61 mutations, including those in the rifampicin resistance-determining region, TIES_PM produces reliable results in good agreement with clinical reference and identifies abnormal data points indicating alternative mechanisms of resistance. In the future, TIES_PM is capable of identifying and selecting leads with a lower risk of resistance evolution and, for smaller proteins, it may systematically predict antibiotic resistance by analyzing all possible codon permutations. Moreover, its flexibility allows for extending predictions to other first-line drugs and drug-resistant diseases. TIES_PM provides a rapid, accurate, low-cost, and scalable supplement to current diagnostic pipelines, particularly for drug resistance screening in both research and clinical domains. IMPORTANCE Antimicrobial resistance (AMR), a global threat, challenges early diagnosis and treatment of tuberculosis (TB). This study employs TIES_PM, a free-energy calculation method, to efficiently predict AMR by quantifying how mutations in bacterial RNA polymerase (RNAP) affect rifampicin (RIF) binding. On simulating 61 clinically observed mutations, the results align with WHO classifications and reveal ambiguous cases, suggesting alternative resistance mechanisms. Each mutation requires ~5 h, offering rapid, cost-effective predictions. An ensemble approach ensures statistical robustness. TIES_PM can be extended to smaller proteins for systematic codon permutation analysis, enabling comprehensive antibiotic resistance prediction, or adapted to identify low-resistance-risk drug leads. It also applies to other TB drugs and resistant pathogens, supporting personalized therapy and global AMR surveillance. This work provides novel tools to refine resistance mutation databases and phenotypic classification standards, enhancing early diagnosis while advancing translational research and infectious disease control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsTuberculosisRifampinDrug Resistance, BacterialTuberculosis, Multidrug-ResistantBacterial ProteinsMycobacterium tuberculosisMicrobial Sensitivity TestsComputer SimulationMolecular Dynamics SimulationReproducibility of ResultsHumansMutation

Stichwörter der Autor:innen

computational biologydrug resistance predictionrifampicin resistancetuberculosis

Substanzen

Antitubercular AgentsRifampinBacterial Proteins

Autor:innen und Institutionen

  • Centre for Computational Science, Department of Chemistry, University College London, London, United Kingdom.
  • Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
  • National Institute of Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, United Kingdom.
  • Advanced Research Computing Centre, University College London, London, United Kingdom.
  • Institute for Informatics, Faculty of Science, University of Amsterdam, Amsterdam, the Netherlands.

ORCID-Profile: Xibei Zhang, Shunzhou Wan, Agastya P Bhati, Philip W Fowler, Peter V Coveney

Förderung

  • Engineering and Physical Sciences Research Council
  • Medical Research Council
  • European Commission
  • U.S. Department of Energy
  • China Scholarship Council

Zitieren

APA

Zhang, X., Wan, S., Bhati, A. P., Fowler, P. W., & Coveney, P. V. (2025). Rapid, accurate, and reproducible de novo prediction of resistance to antituberculars. mSphere. https://doi.org/10.1128/msphere.00571-25

Vancouver

Zhang X, Wan S, Bhati AP, Fowler PW, Coveney PV. Rapid, accurate, and reproducible de novo prediction of resistance to antituberculars. mSphere. 2025. doi:10.1128/msphere.00571-25

BibTeX
@article{Zhang2025,
  author = {Zhang, Xibei and Wan, Shunzhou and Bhati, Agastya P and Fowler, Philip W and Coveney, Peter V},
  title = {Rapid, accurate, and reproducible de novo prediction of resistance to antituberculars},
  journal = {mSphere},
  year = {2025},
  doi = {10.1128/msphere.00571-25}
}
Kostenlos starten →